Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP raptor resources limited

0.00%

20.5¢

All the opinion of the author Isn't it interesting that FDA...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 2 Last

Share
Profile

Follow
Myeverywish

3,464 Posts.

956

08/08/20

17:11

Post #: 46399562
Share

Originally posted by Red bar ↑

A very professional website recently launched:

https://www.sleepcheckapp.com

Love it!!

very impressed with how quickly SleepCheck is developing....

I called the company yesterday, SleepCheck is getting really good traction. They couldn't say how many downloads, but looking really good.... Isobar was paid in cash again they couldn't say any details in relation to how much cash it was but we're not diluting any shares or expecting any dumps so they can be paid, this is good to know as I noted that some were worried about this topic reading through the threads...

ResApp is receiving positive feedback from doctors regarding DX with the recently launched diagnostic software for respiratory disease through ResApp's partners Phenix and Coviu

By the way the Food and Drug Administration is now open for business again as some are aware, looks like our company will be now holding a meeting with them over zoom rather than holding out for a face to face meeting as we could be waiting a while before International flights resume again...This is just the new way of doing business now moving forward.. looking at it from a positive angle that does save us money in travel expenses and brings my expectations more forward in relation to hearing something regarding this topic. Looking forward to any issues being cleared up via TK's comprehensive reply to their queries... As a shareholder I am seriously hoping we can get some positive from America as to date everything that's been looked at over there has been either hit with some issues or delayed... ResApp has spent so much time and money trying to launch the DX software into America it certainly hasn't happened overnight but I think it will happen. Deserves results - wake up FDA and put this through so that our company can launch it's DX software throughout the US. As I stated yesterday I think with this pandemic it has dramatically improved our chances, the risks that the Food and Drug Administration once had should now be overruled by the POSITIVES of our medical diagnostic software due to the fact that so many people are now turning to Telehealth and there is no other accurate tool to diagnose respiratory symptoms without the use of additional hardware or attachments. Doctors are seriously gambling with their patients health when it comes to trying to accurately diagnose ones respiratory symptoms remotely, furthermore our diagnostic software is now being used in the real world so we have excellent data/ evidence to help support our case IMO.. I personally don't see why we will not be granted emergency clearance for the use on adults based on the Australian Data let alone the previous submission for children, on top of this hopefully our company can get a sense of what the FDA require for SleepCheck ( if anything) to be released throughout the United States as a class I tool to screen the population for sleep apnea. Surely the existing data here would suffice considering that this is tested in exactly the same way here in Australia as it is done over in America...

ResApp is still in active discussions with many companies all over the world looking under the hood...

BRING IT ON!!

Have have a great weekend all!

Cheers

Red bar

Expand

All the opinion of the author

Isn't it interesting that FDA meetings using Zoom...and Resapp is for primary use over the same remote tech...especially in today's pandemic situation where it is clear GP visits are increasing going online...to keep population contained....

No stethoscope during a telehealth consultation....to diagnose respiratory distress...

However...Yes there is Resapp dx which is a approved CE and TGA approved respiratory diagnostic tool...that doctors are now using to help determine the best care path for their patients...

As for uptake in respiratory consultations done with Corviu and Phenix...patients are directed in triage to have a Resapp respiratory check before seeing the doctor...
The doctor does not have to sell this...
The platform is selling Resapp dx...

TRIAGE!!!!!!!!!!!!!!!!!

The suits do not understand the significance of medical triage...
Triage is gold for Resapp, Phenrx and Corviu revenue...

An extremely happy Bentley...

RAP Price at posting: 14.5¢ Sentiment: Hold Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Trump just dropped a 200% tariff bomb. Here's how to cash in

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

AII

Inside the depths of Panasqueira: A legacy carved in rock

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

There are more pages in this discussion • 203 more messages in this thread...

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

SPONSORED BY